Table 1.
Patient | Age (years) | Gender | Ray | Histology | Tumor | Radiation | AJCC stage | Margins | Followup (months) | MSTS score | Grip (%) | Current status |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 8 | Female | IF | STS | Primary | No | 2 | Negative | 96 | 30 | 40 | NED |
2 | 51 | Male | IF | NSCLC | Metastasis | Yes | 4 | Negative | 118 | 27 | NA | DOD |
3 | 68 | Female | IF | STS | Primary | No | 2 | Negative | 24 | 27 | 80 | NED |
4 | 75 | Male | IF | STS | Recurrent | No | 2 | Negative | 12 | 29 | NA | NED |
5 | 79 | Female | IF | STS | Recurrent | Yes | 2 | Positive | 12 | 25 | NA | DOC |
6 | 80 | Male | IF | STS | Primary | No | 2 | Negative | 24 | 24 | NA | NED |
7 | 73 | Male | IF | NSCLC | Metastasis | No | 4 | Negative | 2 | NA | NA | DOD |
8 | 27 | Female | MF | GCT bone | Primary | Yes | NA | Negative | 60 | 29 | NA | NED |
9 | 37 | Male | MF | Sweat gland carcinoma | Recurrent | No | 4 | Negative | 12 | 27 | NA | DOD |
10 | 39 | Male | MF | STS | Recurrent | Yes | 2 | Negative | 36 | 28 | NA | NED |
11 | 51 | Female | MF | STS | Primary | Yes | 1 | Negative | 4 | 30 | 94 | NED |
12 | 72 | Male | MF | NSCLC | Metastasis | No | 4 | Negative | 12 | 29 | NA | DOD |
13 | 27 | Female | RF | STS | Primary | No | 2 | Negative | 24 | 29 | 100 | NED |
14 | 29 | Female | RF | GCT bone | Primary | No | NA | Negative | 33 | 29 | 71 | NED |
15 | 40 | Male | RF | Chondrosarcoma | Primary | Yes | 1 | Negative | 120 | 30 | 96 | NED |
16 | 41 | Female | RF | STS | Primary | No | 2 | Negative | 6 | 28 | NA | NED |
17 | 49 | Female | RF | STS | Primary | No | 2 | Negative | 24 | 26 | 38 | NED |
18 | 51 | Female | RF | STS | Primary | No | 2 | Negative | 24 | 28 | 93 | NED |
19 | 12 | Female | LF | STS | Recurrent | No | 2 | Negative | 66 | 28 | 67 | NED |
20 | 27 | Female | LF | STS | Primary | Yes | 2 | Negative | 29 | 21 | NA | NED |
21 | 33 | Female | LF | STS | Primary | No | 2 | Positive | 66 | 25 | NA | NED |
22 | 38 | Male | LF | STS | Primary | Yes | 2 | Negative | 68 | 28 | 70 | NED |
23 | 61 | Female | LF | STS | Primary | Yes | 1 | Negative | 14 | 30 | NA | NED |
24 | 66 | Female | LF | STS | Primary | Yes | 1 | Negative | 6 | 27 | NA | NED |
25 | 86 | Female | LF | RCC | Metastasis | No | 4 | Negative | 12 | 27 | NA | DOD |
AJCC = American Joint Committee on Cancer; MSTS = Musculoskeletal Tumor Society; IF = index finger; MF = middle finger; RF = ring finger; LF = little finger; STS = soft tissue sarcoma; GCT bone = giant cell tumor of the bone; NSCLC = nonsmall-cell lung cancer; RCC = renal cell carcinoma; NA = not available; NED = no evidence of disease; DOD = dead from disease; DOC = dead from other causes.